A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection

NCT02593162 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C Viral Infection
Chronic Hepatitis C
Hepatitis C (HCV)
Hepatitis C Genotype 4

Interventions

DRUG: Faldaprevir
DRUG: TD-6450
DRUG: Ribavirin

Sponsor

Trek Therapeutics, PBC